Skip to main content

Published locations for Phase 2 validates the safety and efficacy of nivolumab with or without ipilimumab in resectable HCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Phase 2 validates the safety and efficacy of nivolumab with or without ipilimumab in resectable HCC

User login

  • Reset your password
  • /content/phase-2-validates-safety-and-efficacy-nivolumab-or-without-ipilimumab-resectable-hcc
  • /fedprac/article/252034/hepatocellular-carcinoma/phase-2-validates-safety-and-efficacy-nivolumab-or